← Back to search results

ClosedFind a Tender · tender
BuyerNHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
StatusClosed
Deadline16 Sept 2022
Value£600,000
Published2 Aug 2022

What is being bought

The CAV UHB have been allocated funding to the total value of GBP600k to support a challenge to Industry for identifying and developing innovative solutions to the scope provided within the main requirement. The intention is to hold engagement market research and testing with industry to identify and explore potential opportunities to help develop innovative solutions that can help to support the challenge. The procurement will be shaped into stages with funding being available subject to project board sign off during the process to enable bidders to develop their proposed solution further; Phase 1 : Development of Concepts (~GBP100k) with funded contribution up to GBP20k available for bidders subject to successful selection (up to a period of 3 months) Phase 2 : Development of Functional Prototype (~GBP200k) with funded contribution up to ~GBP100k available to bidders selected to progress from Phase 1 (Up to a period of 6 months) Phase 3 : Next stage development towards deployable/commercial product with up to ~GBP300k available to bidders selected to progress from Phase 2 The development stages and funds available are provided as a guide and may be subject to change depending on the outcome of the development phases that will help to inform the final Tender. (Up to a period of 6 months) It is anticipated that successful applicants will also contribute direct and in-kind resources during the course of the project although there is no pre-requisite fixed % matched required and each proposal will be considered on a per-case basis.

Delivery location

UKL22 · UKL22

Categories

Health services 85100000Health services 85100000

Lot details

Option 1 - Devices

The final procurement following the market research and engagement dialogue phases may or may not result in the Health Board awarding to 1 or more suppliers based on the outcomes received from the Industry relating to the Challenge. This may be related to devices/ solutions or both Endoscopy waiting lists in Wales continue to face significant pressure. During the height of the pandemic the provision of diagnostic, therapeutic and surveillance endoscopy services were extremely challenged with a significant increase in those awaiting a procedure. Today, even as capacity returns slowly towards normal, the overall numbers of patients awaiting a procedure continues to grow. Strict review and triage of lists has required the absolute prioritisation of urgent and higher risk cases. However, overall time to intervention for such cases is not at the level desired. Patients deemed non-urgent such as those waiting for surveillance colonoscopy and those thought to be at less risk of cancer continue to wait due to the lack of capacity. There is evidence that even patients with high risk symptoms or positive screening tests are also having to wait far longer than desirable. The requirement for in-patient admissions for some patients and the necessary wait before an endoscopic examination can be completed adds additional pressure on availability of beds and overall patient flow through hospitals. Current endoscopy technology is reusable and capital costs are between GBP60,000.00 to GBP100,000.00 per endoscope system. After each use, the endoscope needs to be decontaminated using specialist units costing roughly GBP1 million per year to run. As described above, Endoscopy waiting lists represent a continuing challenge for the NHS in Wales. The additional demand exceeds available capacity therefore, increasing the value secured through spend on endoscopy is critical to secure a sustainable future for the service. The Cardiff and Vale University Health Board (UHB) are looking to offer the opportunity to rapidly assess and develop novel solutions and technologies that have the potential to accelerate disruptive innovation in reducing the burden of work on endoscopy suites, which could cover several areas such as Technologies or approaches that would obviate the need for an endoscopic procedure such as (but not limited to) : - New training methods to upskill Health Care Professionals to improve the quality of referrals and increase workforce capacity - New endoscopy procedures and approaches - Faster decontamination/cleaning/workflow systems - Development and/or implementation of new non-invasive technology - AI/advance analytics to monitor, manage and signpost patients on the waiting list The aims are as follows; - Better management of demand, ensuring maximum value is delivered by the service whilst maintaining a high quality, safe service - People will get a Faster, definitive diagnosis - Improved capacity and capability within the service - Fewer complications -Improved, expedited recovery and discharge from hospital Additional information: The intention is to release funding at each stage of the Challenge process to fund shortlisted organisations to undertake R&D as the project progresses.

Statusactive

Option 2 - Solution

The final procurement following the market research and engagement dialogue phases may or may not result in the Health Board awarding to 1 or more suppliers based on the outcomes received from the Industry relating to the Challenge. This may be related to devices/ solutions or both Endoscopy waiting lists in Wales continue to face significant pressure. During the height of the pandemic the provision of diagnostic, therapeutic and surveillance endoscopy services were extremely challenged with a significant increase in those awaiting a procedure. Today, even as capacity returns slowly towards normal, the overall numbers of patients awaiting a procedure continues to grow. Strict review and triage of lists has required the absolute prioritisation of urgent and higher risk cases. However, overall time to intervention for such cases is not at the level desired. Patients deemed non-urgent such as those waiting for surveillance colonoscopy and those thought to be at less risk of cancer continue to wait due to the lack of capacity. There is evidence that even patients with high risk symptoms or positive screening tests are also having to wait far longer than desirable. The requirement for in-patient admissions for some patients and the necessary wait before an endoscopic examination can be completed adds additional pressure on availability of beds and overall patient flow through hospitals. Current endoscopy technology is reusable and capital costs are between GBP60,000.00 to GBP100,000.00 per endoscope system. After each use, the endoscope needs to be decontaminated using specialist units costing roughly GBP1 million per year to run. As described above, Endoscopy waiting lists represent a continuing challenge for the NHS in Wales. The additional demand exceeds available capacity therefore, increasing the value secured through spend on endoscopy is critical to secure a sustainable future for the service. The Cardiff and Vale University Health Board (UHB) are looking to offer the opportunity to rapidly assess and develop novel solutions and technologies that have the potential to accelerate disruptive innovation in reducing the burden of work on endoscopy suites, which could cover several areas such as Technologies or approaches that would obviate the need for an endoscopic procedure such as (but not limited to) : - New training methods to upskill Health Care Professionals to improve the quality of referrals and increase workforce capacity - New endoscopy procedures and approaches - Faster decontamination/cleaning/workflow systems - Development and/or implementation of new non-invasive technology - AI/advance analytics to monitor, manage and signpost patients on the waiting list The aims are as follows; - Better management of demand, ensuring maximum value is delivered by the service whilst maintaining a high quality, safe service - People will get a Faster, definitive diagnosis - Improved capacity and capability within the service - Fewer complications -Improved, expedited recovery and discharge from hospital

Statusactive

What is included

ItemCategoryQuantity
1Health servicesNot published
2Health servicesNot published

Comparable-procurement analytics

Benchmarked against retained Find a Tender procedures with CPV division 85. The category anchor is Health services (85100000); this is a deliberately broad market comparator. The comparison is shown at several levels rather than pretending one company or region is always the best benchmark.

Comparison setProceduresReported bids per procedureNamed award suppliersPrice evidence
Market: CPV division 8538,3731 median · 19.7 average (22,930 of 38,373 with a bid count)1.8 average (24,592 of 38,373 with named award suppliers)10 comparable price pairs
Same buyer42.5 median · 2.5 average (2 of 4 with a bid count)1 average (2 of 4 with named award suppliers)Not published
Delivery region: UKL222141 median · 12.3 average (58 of 214 with a bid count)1.5 average (95 of 214 with named award suppliers)Not published
Similar published value (0.5×–2×)1,2422 median · 3.7 average (23 of 1,242 with a bid count)1 average (25 of 1,242 with named award suppliers)3 comparable price pairs

“Reported bids” is an official aggregate, sometimes reported per lot; it is the closest available competition measure. “Named award suppliers” are winners, not all applicants.

Indicative price outcome

£390,360 is the median lowest-valid-bid benchmark for the broad CPV market sample, against this procedure’s published value of £600,000.

This is a historical comparator, not a bid-price forecast or a guaranteed saving. It excludes records where the published values cannot be sensibly compared and does not adjust for lot structure, quality weighting, framework terms or scope.

Procurement strategy & market signals

Framework agreementNot published
Dynamic purchasing systemNot published
Competitive procurementNot published
Recurring requirementNot published
Procurement method rationaleNot published
Rationale classificationsNot published
Special regimeNot published
Covered byNot published
Submission policyNot published
Selection criteriaNot published
Risk detailsNot published

Planning & early market engagement

BudgetNot published
No-engagement rationaleNot published
Planning documents0
Planning milestones0

No planning milestones published.

Related procurements

No linked framework, prior procurement or reprocurement published.

Documents & submission route

No documents are published in the current source record.

Source data inventory

Diagnostic view. “Not published” means this current release does not provide a value.

OCIDocds-h6vhtk-035847
Latest release ID021130-2022
Latest release timestampTue Aug 02 2022 13:56:03 GMT+0000 (Coordinated Universal Time)
Sourcefind-a-tender
Official notice URLNot published
Tender statusactive
Procurement methodselective
Procurement method detailsProcedure involving negotiations
Main procurement categoryservices
Above thresholdNot published
Legal basis32014L0024
Tender period: startNot published
Tender period: end2022-09-16T12:00:00+01:00
Expression of interest deadlineNot published
Enquiry deadlineNot published
Award period: startNot published
Award period: endNot published
Submission method detailshttps://etenderwales.bravosolution.co.uk
Submission languagesen
Electronic catalogue policyNot published
Total tender value£600,000
Tender lots in source2
Tender items in source2
Tender documents in source0
Awards in latest release0
Contracts in latest release0
Parties in latest release2

Notice history

DateEventReference
2 Aug 2022tender021130-2022

All source data

Unmodified official OCDS data retained by Tenderline for this procurement process.

Complete current OCDS release JSON
{
  "id": "021130-2022",
  "tag": [
    "tender"
  ],
  "date": "2022-08-02T14:56:03+01:00",
  "ocid": "ocds-h6vhtk-035847",
  "buyer": {
    "id": "GB-FTS-42587",
    "name": "NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)"
  },
  "tender": {
    "id": "CAV-OJEU-PROJECT_50942",
    "lots": [
      {
        "id": "1",
        "title": "Option 1 - Devices",
        "status": "active",
        "description": "The final procurement following the market research and engagement dialogue phases may or may not result in the Health Board awarding to 1 or more suppliers based on the outcomes received from the Industry relating to the Challenge.  This may be related to devices/ solutions or both\nEndoscopy waiting lists in Wales continue to face significant pressure. During the height of the pandemic the provision of diagnostic, therapeutic and surveillance endoscopy services were extremely challenged with a significant increase in those awaiting a procedure. Today, even as capacity returns slowly towards normal, the overall numbers of patients awaiting a procedure continues to grow.\nStrict review and triage of lists has required the absolute prioritisation of  urgent and higher risk cases.  However, overall time to intervention for such cases is not at the level desired.\nPatients deemed non-urgent such as those waiting for surveillance colonoscopy and those thought to be at less risk of cancer continue to wait due to the lack of capacity. There is evidence that even patients with high risk symptoms or positive screening tests are also having to wait far longer than desirable. The requirement for in-patient admissions for some patients and the necessary wait before an endoscopic examination can be completed adds additional pressure on availability of beds and overall patient flow through hospitals.\nCurrent endoscopy technology is reusable and capital costs are between GBP60,000.00 to GBP100,000.00 per endoscope system. After each use, the endoscope needs to be decontaminated using specialist units costing roughly GBP1 million per year to run.\nAs described above, Endoscopy waiting lists represent a continuing challenge for the NHS in Wales. The additional demand exceeds available capacity therefore, increasing the value secured through spend on endoscopy is critical to secure a sustainable future for the service.\nThe Cardiff and Vale University Health Board (UHB) are looking to offer the opportunity to rapidly assess and develop novel solutions and technologies that have the potential to accelerate disruptive innovation in reducing the burden of work on endoscopy suites, which could\ncover several areas such as Technologies or approaches that would obviate the need for an endoscopic procedure such as (but not limited to) :\n- New training methods to upskill Health Care Professionals to improve the quality of referrals and increase workforce capacity\n- New endoscopy procedures and approaches\n- Faster decontamination/cleaning/workflow systems\n- Development and/or implementation of new non-invasive technology\n- AI/advance analytics to monitor, manage and signpost patients on the waiting list\nThe aims are as follows;\n- Better management of demand, ensuring maximum value is delivered by the service whilst maintaining a high quality, safe service\n- People will get a Faster, definitive diagnosis\n- Improved capacity and capability within the service\n- Fewer complications\n-Improved, expedited recovery and discharge from hospital Additional information: The intention is to release funding at each stage of the Challenge process to fund shortlisted organisations to undertake R&D as the project progresses."
      },
      {
        "id": "2",
        "title": "Option 2 - Solution",
        "status": "active",
        "description": "The final procurement following the market research and engagement dialogue phases may or may not result in the Health Board awarding to 1 or more suppliers based on the outcomes received from the Industry relating to the Challenge.  This may be related to devices/ solutions or both\nEndoscopy waiting lists in Wales continue to face significant pressure. During the height of the pandemic the provision of diagnostic, therapeutic and surveillance endoscopy services were extremely challenged with a significant increase in those awaiting a procedure. Today, even as capacity returns slowly towards normal, the overall numbers of patients awaiting a procedure continues to grow.\nStrict review and triage of lists has required the absolute prioritisation of  urgent and higher risk cases.  However, overall time to intervention for such cases is not at the level desired.\nPatients deemed non-urgent such as those waiting for surveillance colonoscopy and those thought to be at less risk of cancer continue to wait due to the lack of capacity. There is evidence that even patients with high risk symptoms or positive screening tests are also having to wait far longer than desirable. The requirement for in-patient admissions for some patients and the necessary wait before an endoscopic examination can be completed adds additional pressure on availability of beds and overall patient flow through hospitals.\nCurrent endoscopy technology is reusable and capital costs are between GBP60,000.00 to GBP100,000.00 per endoscope system. After each use, the endoscope needs to be decontaminated using specialist units costing roughly GBP1 million per year to run.\nAs described above, Endoscopy waiting lists represent a continuing challenge for the NHS in Wales. The additional demand exceeds available capacity therefore, increasing the value secured through spend on endoscopy is critical to secure a sustainable future for the service.\nThe Cardiff and Vale University Health Board (UHB) are looking to offer the opportunity to rapidly assess and develop novel solutions and technologies that have the potential to accelerate disruptive innovation in reducing the burden of work on endoscopy suites, which could\ncover several areas such as Technologies or approaches that would obviate the need for an endoscopic procedure such as (but not limited to) :\n- New training methods to upskill Health Care Professionals to improve the quality of referrals and increase workforce capacity\n- New endoscopy procedures and approaches\n- Faster decontamination/cleaning/workflow systems\n- Development and/or implementation of new non-invasive technology\n- AI/advance analytics to monitor, manage and signpost patients on the waiting list\nThe aims are as follows;\n- Better management of demand, ensuring maximum value is delivered by the service whilst maintaining a high quality, safe service\n- People will get a Faster, definitive diagnosis\n- Improved capacity and capability within the service\n- Fewer complications\n-Improved, expedited recovery and discharge from hospital"
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryAddresses": [
          {
            "region": "UKL22"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85100000",
            "scheme": "CPV",
            "description": "Health services"
          }
        ]
      },
      {
        "id": "2",
        "relatedLot": "2",
        "deliveryAddresses": [
          {
            "region": "UKL22"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85100000",
            "scheme": "CPV",
            "description": "Health services"
          }
        ]
      }
    ],
    "title": "CCR Endoscopy Challenge",
    "value": {
      "amount": 600000,
      "currency": "GBP"
    },
    "status": "active",
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "description": "The CAV UHB have been allocated funding to the total value of GBP600k to support a challenge to Industry for identifying and developing innovative solutions to the scope provided within the main requirement.\nThe intention is to hold engagement market research and testing with industry to identify and explore potential opportunities to help develop innovative solutions that can help to support the challenge.  The procurement will be shaped into stages with funding being available  subject to project board sign off during the process to enable bidders to develop their proposed solution further;\nPhase 1 : Development of Concepts (~GBP100k) with funded contribution up to GBP20k available for bidders subject to successful selection (up to a period of 3 months)\nPhase 2 : Development of Functional Prototype (~GBP200k) with funded contribution up to ~GBP100k available to bidders selected to progress from Phase 1 (Up to a period of 6 months)\nPhase 3 : Next stage development towards deployable/commercial product with up to ~GBP300k  available to bidders selected to progress from Phase 2\nThe development stages and funds available are provided as a guide and may be subject to change depending on the outcome of the development phases that will help to inform the final Tender. (Up to a period of 6 months)\nIt is anticipated that successful applicants will also contribute direct and in-kind resources during the course of the project although there is no pre-requisite fixed % matched required and each proposal will be considered on a per-case basis.",
    "tenderPeriod": {
      "endDate": "2022-09-16T12:00:00+01:00"
    },
    "contractTerms": {
      "performanceTerms": "The funding provided is to support innovation and there will be some scored criteria that will cover the related links to social, economic and community benefits",
      "hasElectronicPayment": true,
      "hasElectronicOrdering": true,
      "electronicInvoicingPolicy": "allowed"
    },
    "reviewDetails": "Precise information on deadline(s) for review procedures:\nNHS Wales Shared Services Partnership on behalf of Cardiff and Vale University Local Health Board will allow a minimum 10 calendar day standstill period between notifying the award decision and awarding the contract. Unsuccessful tenderers and applicants are entitled to receive reasons for the decision, including the characteristics and relative advantages of the winning bid and the reasons why the tenderer/applicant was unsuccessful.\nShould additional information be required it should be requested of the addressee in section I.1. Aggrieved parties who have been harmed or are at risk of harm by breach of the procurement rules have the right to take action in the High Court (England and Wales). Any such action is subject to strict time limits in accordance with the Public Contracts (Amendments) Regulations 2015.",
    "classification": {
      "id": "85100000",
      "scheme": "CPV",
      "description": "Health services"
    },
    "submissionTerms": {
      "languages": [
        "en"
      ]
    },
    "submissionMethod": [
      "electronicSubmission"
    ],
    "otherRequirements": {
      "reductionCriteria": "The Health Board is seeking to engage in dialogue with providers who are able to provide an innovative approach/solution to meeting the needs of this challenge.  We are not looking for anything already available that is market ready and intend to use the funding available to help support industry into moving ideas into development and commercialisation to support the challenge going forward.\nThere will be a qualification stage set for participation and shortlisting and then following initial dialogue further information will be shared around the criteria for shortlisting and allocation of funds to the shortlisted providers to commence Phase 1 of the Development stage, and so on to the remaining phases until we reach the final Tender stage for taking a preferred solution through to final tender process and award."
    },
    "procurementMethod": "selective",
    "mainProcurementCategory": "services",
    "submissionMethodDetails": "https://etenderwales.bravosolution.co.uk",
    "procurementMethodDetails": "Procedure involving negotiations"
  },
  "parties": [
    {
      "id": "GB-FTS-42587",
      "name": "NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UK",
        "locality": "Cardiff",
        "postalCode": "CF14 4HH",
        "countryName": "United Kingdom",
        "streetAddress": "Procurement Services, Cardiff and Vale University Local Health Board, Woodlands House, 2nd Floor, Maes-Y-Coed Road"
      },
      "details": {
        "url": "http://nwssp.nhs.wales/ourservices/procurement-services/",
        "buyerProfile": "https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "legalName": "NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)"
      },
      "contactPoint": {
        "email": "sarah.yellen@wales.nhs.uk",
        "telephone": "+44 1443848585"
      }
    },
    {
      "id": "GB-FTS-111",
      "name": "High Court",
      "roles": [
        "reviewBody"
      ],
      "address": {
        "locality": "London",
        "postalCode": "WC2A 2LL",
        "countryName": "United Kingdom",
        "streetAddress": "Royal Courts of Justice, The Strand"
      },
      "identifier": {
        "legalName": "High Court"
      },
      "contactPoint": {
        "telephone": "+44 2079477501"
      }
    }
  ],
  "language": "en",
  "description": "Please note additional information on this procurement:\n1. The Contracting Authority reserves the right to award the contract in whole, in part or annul the tendering process and not award any\ncontract.\n2. Bidders should note that they will be required to enter into terms and conditions of contract as set out in the ITT and that save for matters of clarification or consistency the Contracting Authority will not negotiate the terms.\n3. The Contracting Authority will not accept completed ITT's after the stated closing date.\n4. All documents to be priced (where applicable) in sterling and all payments made in sterling.\n5. All tender costs and liabilities incurred by bidders shall be the sole responsibility of the bidders.\n6. Prospective suppliers should note that NHS Shared Services Partnership - Procurement Services is acting on behalf of Cardiff and Vale University Local Health Board.\n7. This Procurement is being undertaken via the Light Touch Regime.\n8. Bidders wishing to participate should visit the Bravo e-tenderwales portal\nNOTE: The authority is using eTenderwales to carry out this procurement process. To obtain further information record your interest on Sell2Wales at https://www.sell2wales.gov.wales\nNOTE: The authority is using eTenderwales to carry out this procurement process. To obtain further information record your interest on Sell2Wales at https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=123420\n(WA Ref:123420)",
  "initiationType": "tender"
}
Complete JSON history (1 releases)
2 Aug 2022 · 021130-2022 · tender
{
  "id": "021130-2022",
  "tag": [
    "tender"
  ],
  "date": "2022-08-02T14:56:03+01:00",
  "ocid": "ocds-h6vhtk-035847",
  "buyer": {
    "id": "GB-FTS-42587",
    "name": "NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)"
  },
  "tender": {
    "id": "CAV-OJEU-PROJECT_50942",
    "lots": [
      {
        "id": "1",
        "title": "Option 1 - Devices",
        "status": "active",
        "description": "The final procurement following the market research and engagement dialogue phases may or may not result in the Health Board awarding to 1 or more suppliers based on the outcomes received from the Industry relating to the Challenge.  This may be related to devices/ solutions or both\nEndoscopy waiting lists in Wales continue to face significant pressure. During the height of the pandemic the provision of diagnostic, therapeutic and surveillance endoscopy services were extremely challenged with a significant increase in those awaiting a procedure. Today, even as capacity returns slowly towards normal, the overall numbers of patients awaiting a procedure continues to grow.\nStrict review and triage of lists has required the absolute prioritisation of  urgent and higher risk cases.  However, overall time to intervention for such cases is not at the level desired.\nPatients deemed non-urgent such as those waiting for surveillance colonoscopy and those thought to be at less risk of cancer continue to wait due to the lack of capacity. There is evidence that even patients with high risk symptoms or positive screening tests are also having to wait far longer than desirable. The requirement for in-patient admissions for some patients and the necessary wait before an endoscopic examination can be completed adds additional pressure on availability of beds and overall patient flow through hospitals.\nCurrent endoscopy technology is reusable and capital costs are between GBP60,000.00 to GBP100,000.00 per endoscope system. After each use, the endoscope needs to be decontaminated using specialist units costing roughly GBP1 million per year to run.\nAs described above, Endoscopy waiting lists represent a continuing challenge for the NHS in Wales. The additional demand exceeds available capacity therefore, increasing the value secured through spend on endoscopy is critical to secure a sustainable future for the service.\nThe Cardiff and Vale University Health Board (UHB) are looking to offer the opportunity to rapidly assess and develop novel solutions and technologies that have the potential to accelerate disruptive innovation in reducing the burden of work on endoscopy suites, which could\ncover several areas such as Technologies or approaches that would obviate the need for an endoscopic procedure such as (but not limited to) :\n- New training methods to upskill Health Care Professionals to improve the quality of referrals and increase workforce capacity\n- New endoscopy procedures and approaches\n- Faster decontamination/cleaning/workflow systems\n- Development and/or implementation of new non-invasive technology\n- AI/advance analytics to monitor, manage and signpost patients on the waiting list\nThe aims are as follows;\n- Better management of demand, ensuring maximum value is delivered by the service whilst maintaining a high quality, safe service\n- People will get a Faster, definitive diagnosis\n- Improved capacity and capability within the service\n- Fewer complications\n-Improved, expedited recovery and discharge from hospital Additional information: The intention is to release funding at each stage of the Challenge process to fund shortlisted organisations to undertake R&D as the project progresses."
      },
      {
        "id": "2",
        "title": "Option 2 - Solution",
        "status": "active",
        "description": "The final procurement following the market research and engagement dialogue phases may or may not result in the Health Board awarding to 1 or more suppliers based on the outcomes received from the Industry relating to the Challenge.  This may be related to devices/ solutions or both\nEndoscopy waiting lists in Wales continue to face significant pressure. During the height of the pandemic the provision of diagnostic, therapeutic and surveillance endoscopy services were extremely challenged with a significant increase in those awaiting a procedure. Today, even as capacity returns slowly towards normal, the overall numbers of patients awaiting a procedure continues to grow.\nStrict review and triage of lists has required the absolute prioritisation of  urgent and higher risk cases.  However, overall time to intervention for such cases is not at the level desired.\nPatients deemed non-urgent such as those waiting for surveillance colonoscopy and those thought to be at less risk of cancer continue to wait due to the lack of capacity. There is evidence that even patients with high risk symptoms or positive screening tests are also having to wait far longer than desirable. The requirement for in-patient admissions for some patients and the necessary wait before an endoscopic examination can be completed adds additional pressure on availability of beds and overall patient flow through hospitals.\nCurrent endoscopy technology is reusable and capital costs are between GBP60,000.00 to GBP100,000.00 per endoscope system. After each use, the endoscope needs to be decontaminated using specialist units costing roughly GBP1 million per year to run.\nAs described above, Endoscopy waiting lists represent a continuing challenge for the NHS in Wales. The additional demand exceeds available capacity therefore, increasing the value secured through spend on endoscopy is critical to secure a sustainable future for the service.\nThe Cardiff and Vale University Health Board (UHB) are looking to offer the opportunity to rapidly assess and develop novel solutions and technologies that have the potential to accelerate disruptive innovation in reducing the burden of work on endoscopy suites, which could\ncover several areas such as Technologies or approaches that would obviate the need for an endoscopic procedure such as (but not limited to) :\n- New training methods to upskill Health Care Professionals to improve the quality of referrals and increase workforce capacity\n- New endoscopy procedures and approaches\n- Faster decontamination/cleaning/workflow systems\n- Development and/or implementation of new non-invasive technology\n- AI/advance analytics to monitor, manage and signpost patients on the waiting list\nThe aims are as follows;\n- Better management of demand, ensuring maximum value is delivered by the service whilst maintaining a high quality, safe service\n- People will get a Faster, definitive diagnosis\n- Improved capacity and capability within the service\n- Fewer complications\n-Improved, expedited recovery and discharge from hospital"
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryAddresses": [
          {
            "region": "UKL22"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85100000",
            "scheme": "CPV",
            "description": "Health services"
          }
        ]
      },
      {
        "id": "2",
        "relatedLot": "2",
        "deliveryAddresses": [
          {
            "region": "UKL22"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85100000",
            "scheme": "CPV",
            "description": "Health services"
          }
        ]
      }
    ],
    "title": "CCR Endoscopy Challenge",
    "value": {
      "amount": 600000,
      "currency": "GBP"
    },
    "status": "active",
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "description": "The CAV UHB have been allocated funding to the total value of GBP600k to support a challenge to Industry for identifying and developing innovative solutions to the scope provided within the main requirement.\nThe intention is to hold engagement market research and testing with industry to identify and explore potential opportunities to help develop innovative solutions that can help to support the challenge.  The procurement will be shaped into stages with funding being available  subject to project board sign off during the process to enable bidders to develop their proposed solution further;\nPhase 1 : Development of Concepts (~GBP100k) with funded contribution up to GBP20k available for bidders subject to successful selection (up to a period of 3 months)\nPhase 2 : Development of Functional Prototype (~GBP200k) with funded contribution up to ~GBP100k available to bidders selected to progress from Phase 1 (Up to a period of 6 months)\nPhase 3 : Next stage development towards deployable/commercial product with up to ~GBP300k  available to bidders selected to progress from Phase 2\nThe development stages and funds available are provided as a guide and may be subject to change depending on the outcome of the development phases that will help to inform the final Tender. (Up to a period of 6 months)\nIt is anticipated that successful applicants will also contribute direct and in-kind resources during the course of the project although there is no pre-requisite fixed % matched required and each proposal will be considered on a per-case basis.",
    "tenderPeriod": {
      "endDate": "2022-09-16T12:00:00+01:00"
    },
    "contractTerms": {
      "performanceTerms": "The funding provided is to support innovation and there will be some scored criteria that will cover the related links to social, economic and community benefits",
      "hasElectronicPayment": true,
      "hasElectronicOrdering": true,
      "electronicInvoicingPolicy": "allowed"
    },
    "reviewDetails": "Precise information on deadline(s) for review procedures:\nNHS Wales Shared Services Partnership on behalf of Cardiff and Vale University Local Health Board will allow a minimum 10 calendar day standstill period between notifying the award decision and awarding the contract. Unsuccessful tenderers and applicants are entitled to receive reasons for the decision, including the characteristics and relative advantages of the winning bid and the reasons why the tenderer/applicant was unsuccessful.\nShould additional information be required it should be requested of the addressee in section I.1. Aggrieved parties who have been harmed or are at risk of harm by breach of the procurement rules have the right to take action in the High Court (England and Wales). Any such action is subject to strict time limits in accordance with the Public Contracts (Amendments) Regulations 2015.",
    "classification": {
      "id": "85100000",
      "scheme": "CPV",
      "description": "Health services"
    },
    "submissionTerms": {
      "languages": [
        "en"
      ]
    },
    "submissionMethod": [
      "electronicSubmission"
    ],
    "otherRequirements": {
      "reductionCriteria": "The Health Board is seeking to engage in dialogue with providers who are able to provide an innovative approach/solution to meeting the needs of this challenge.  We are not looking for anything already available that is market ready and intend to use the funding available to help support industry into moving ideas into development and commercialisation to support the challenge going forward.\nThere will be a qualification stage set for participation and shortlisting and then following initial dialogue further information will be shared around the criteria for shortlisting and allocation of funds to the shortlisted providers to commence Phase 1 of the Development stage, and so on to the remaining phases until we reach the final Tender stage for taking a preferred solution through to final tender process and award."
    },
    "procurementMethod": "selective",
    "mainProcurementCategory": "services",
    "submissionMethodDetails": "https://etenderwales.bravosolution.co.uk",
    "procurementMethodDetails": "Procedure involving negotiations"
  },
  "parties": [
    {
      "id": "GB-FTS-42587",
      "name": "NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UK",
        "locality": "Cardiff",
        "postalCode": "CF14 4HH",
        "countryName": "United Kingdom",
        "streetAddress": "Procurement Services, Cardiff and Vale University Local Health Board, Woodlands House, 2nd Floor, Maes-Y-Coed Road"
      },
      "details": {
        "url": "http://nwssp.nhs.wales/ourservices/procurement-services/",
        "buyerProfile": "https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "legalName": "NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)"
      },
      "contactPoint": {
        "email": "sarah.yellen@wales.nhs.uk",
        "telephone": "+44 1443848585"
      }
    },
    {
      "id": "GB-FTS-111",
      "name": "High Court",
      "roles": [
        "reviewBody"
      ],
      "address": {
        "locality": "London",
        "postalCode": "WC2A 2LL",
        "countryName": "United Kingdom",
        "streetAddress": "Royal Courts of Justice, The Strand"
      },
      "identifier": {
        "legalName": "High Court"
      },
      "contactPoint": {
        "telephone": "+44 2079477501"
      }
    }
  ],
  "language": "en",
  "description": "Please note additional information on this procurement:\n1. The Contracting Authority reserves the right to award the contract in whole, in part or annul the tendering process and not award any\ncontract.\n2. Bidders should note that they will be required to enter into terms and conditions of contract as set out in the ITT and that save for matters of clarification or consistency the Contracting Authority will not negotiate the terms.\n3. The Contracting Authority will not accept completed ITT's after the stated closing date.\n4. All documents to be priced (where applicable) in sterling and all payments made in sterling.\n5. All tender costs and liabilities incurred by bidders shall be the sole responsibility of the bidders.\n6. Prospective suppliers should note that NHS Shared Services Partnership - Procurement Services is acting on behalf of Cardiff and Vale University Local Health Board.\n7. This Procurement is being undertaken via the Light Touch Regime.\n8. Bidders wishing to participate should visit the Bravo e-tenderwales portal\nNOTE: The authority is using eTenderwales to carry out this procurement process. To obtain further information record your interest on Sell2Wales at https://www.sell2wales.gov.wales\nNOTE: The authority is using eTenderwales to carry out this procurement process. To obtain further information record your interest on Sell2Wales at https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=123420\n(WA Ref:123420)",
  "initiationType": "tender"
}